Quebec Life Science Companies and Organizations to Exhibit at BioJapan 2025
Quebec Government Office in Tokyo
From October 8 (Wed) to 10 (Fri), 2025, ten life science companies and organizations from Quebec, Canada will visit Japan to participate in BioJapan 2025!
Booth: B-111
This is a unique opportunity to discover the latest innovations from Quebec, one of North America’s leading biotech hubs.
Information about Quebec’s life sciences ecosystem and participating companies can be found on the websites below.
For those interested in meetings or information exchange, please feel free to contact us.
Participating Companies
- Avitia:
Based in Montreal. Partnered with the AI research institute Mila, Avitia provides a fast and cost-effective AI-powered genetic mutation testing platform for cancer, with the goal of global expansion. - Altascience:
A contract research organization (CRO) headquartered in Laval, Quebec. Strong in early-phase development (Preclinical to Phase II) with multiple clinical and research sites across Canada and the U.S. - BioQuébec:
A non-profit organization representing Quebec’s life sciences and healthtech industries. With around 280 member companies, it promotes collaboration and innovation across the sector. - Domaine Thérapeutic:
A biopharmaceutical company collaborating with Université de Montréal to develop a novel drug discovery platform targeting GPCRs. - Immugenia Inc.:
Based in Sherbrooke, Quebec. An immuno-oncology startup developing next-generation CAR therapies using hematopoietic stem cells to prevent cancer relapse. - Miso Chip:
A biotech company from Montreal developing “tumor-on-a-chip” technology that recreates the tumor microenvironment for personalized cancer treatment and preclinical evaluation. - Novatek International:
A Montreal-based regulatory compliance software company offering LIMS and quality control/environmental monitoring solutions for the biopharma industry. - Neurenati Therapeutics Inc.:
Based in Montreal. Developing innovative non-surgical therapies for rare diseases such as Hirschsprung’s disease. - National Research Council Canada – Human Health Therapeutics Research Centre:
Canada’s largest dedicated biopharmaceutical R&D team, collaborating with industry, hospitals, health networks, academia, and government to develop new biopharmaceuticals. - PharmBD Inc.:
A consulting firm seeking partners for co-development or licensing projects in neurology and addiction fields as part of its portfolio.
Overview Documents (PDF)
Detailed information on the participating companies is available below:
📄 Japanese PDF
📄 English PDF
Author:
Quebec Government Office in Tokyo
Commercial Attaché, Life Sciences
Emi Kokado – emi.kokado@mri.gouv.qc.ca
